Russell Scammell

Director Small Molecule Drug Discovery
Charles River Laboratories
Harlow, England, United Kingdom

Russell Scammell BSc (Hons) - Charles River Laboratories

Russell Scammell is currently a Director of small molecule drug discovery at Charles River. He has worked in the pharmaceutical industry for over 30 years at all stages of research and development where he has led the Pharmaceutics, Formulation, Chemistry and Analytical sciences groups at Aventis, Argenta Discovery and Charles River. Russell joined Charles River in 2014 and his primary role has been providing industry leading delivery of small molecule drug discovery pharmaceutical sciences and preclinical development expertise.

Disclosure information not submitted.

Presentation(s):

• Understanding Formulation Challenges Early to Accelerate Timelines for FIH Trials

  Monday, October 17, 2022
  9:00 AM – 10:00 AM ET